Previous Meetings

GBCC 2011

Global Breast Cancer Conference 2011

08:30-09:50
Panel I
New Novel/Emerging Targeted Therapy in Breast Cancer
Venue: Vista I+II+III
  • Targeted Therapy for Breast Cancer: Reviews of Past Decade and Future Challenge
    Ian Krop (Department of Medical Oncology, Dana-Farber Cancer Institute, U.S.A.)
  • Discovery of Molecular Predictors and Identification of Subgroup in the Era of Targeted Therapy
    Eric P. Winer (Breast Oncology Center, Dana-Farber Cancer Institute, U.S.A.)
  • Statistical Designs of Clinical Trials of Target Therapy
    Sally Hunsberger (Biostatistics Research Branch, National Cancer Institute, U.S.A.)
Panel II
What Is Hot in Patients with Young Breast Cancer?
Venue: MGB I+II
  • Local Therapy for Young Breast Cancer Patient
    Young-jin Suh (Department of General Surgery, The Catholic Univ. of Korea, St. Vincent Hospital, Korea)
  • Reproductive and Gynecologic Issues
    Yong-Man Kim (Cancer Center, ASAN Medical Center, Korea)
  • Biologic Features in Young Breast Cancer - The Trend of Breast Cancer Incidence Calculated by NSABP/GAIL Model
    Toshiaki Saeki (Department of Breast Oncology, Saitama Medical Univ. International Medical Center, Japan)
09:50-11:10
Panel III
Neoadjuvant Therapy for Breast Cancer
Venue: Vista I+II+III
  • Current and Future Roles of Primary Chemotherapy in Patients with Operable Breast Cancer
    Yen-Shen Lu (Department of Oncology, National Taiwan Univ. Hospital, Taiwan)
  • Predicting Neoadjuvant Therapy Responsiveness and Response Evaluation
    Yeon Hee Park (Department of Hematology-oncology, Samsung Medical Center, Korea)
  • Preoperative Therapy for Breast Cancer
    Soo Chin Lee (Department of Hemato-oncology, National Univ. Health System, Singapore)
Panel IV
What Is Hot in Breast Cancer Translational Research?
Venue: MGB I+II
  • New Powerful Molecular Analytical Tools for Translational Research - A Technical Review
    Chungyeul Kim (Department of Pathology, NSABP Foundation, Inc., U.S.A.)
  • Efforts of Translational Research in Last Decade: Discovery of Gene Expression Signature for Prognostication and Prediction
    Janice Tsang (Department of Clinical Oncology, The Univ. of Hong Kong, Hong Kong)
  • Nanomedicine in Breast Cancer Diagnosis and Treatment: Visualization of Molecular Pathways and Quantification of HER2 Protein by Fluorescent-labelled Antibody
    Noriaki Ohuchi (Department of Surgical Oncology, Tohoku Univ. Hospital, Japan)
  • Statistical Design of Clinical Trials
    Sally Hunsberger (Biostatistics Research Branch, National Cancer Institute, U.S.A.)
11:30-12:10
Plenary II
Venue: Vista I+II+III
  • Molecular Sub-classification of Breast Cancer in the Era of Personalized Medicine
    Soonmyung Paik (Division of Pathology, NSABP Foundation, Inc., U.S.A.)
12:10-13:30
Luncheon Symposium
Supported by GSK
Venue: Vista I+II+III
  • Overcoming Trastuzumab Resistance in ErbB2+Metastatic Breast Cancer
    Mark Pegram (Sylvester Comprehensive Cancer Center, U.S.A.)
13:30-14:50
Panel V
Prognostic and Predictive Markers of Breast Cancer
Venue: Vista I+II
  • Prognostic and Predictive Markers in Breast Cancer
    Sandra J. Shin (Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital-Weill, U.S.A.)
  • Promise of New Developing Preclinical Biomarkers
    Wonshik Han (Department of Surgery, College of Medicine, Seoul National Univ. Hospital, Korea)
  • Emerging Biomarkers in Neoadjuvant Endocrine Therapy
    Charles Coombes (Division of Cancer, Imperial College London, United Kingdom)
Symposium XI
Impact of Nursing Care on the QoL of Women with Breast Cancer
Venue: MGB I
  • Distress of Altered Appearance: Breast Cancer Patient Cohort Study
    Juhee Cho (Cancer Education Center, Samsung Comprehensive Cancer Center, Samsung Medical Center, Korea)
  • Impact of Daily Activity and Physical Condition on QoL of Women Receiving Cancer Chemotherapy
    Akiko Tonosaki (Department of Oncology Nursing and Adult Nursing, National College of Nursing, Japan)
  • Female Sexual Function in Women with Breast Cancer
    Nami Chun (Department of Nursing, Sungshin Women’s Univ., Korea)
  • Mobilixing Survivors for Advocacy and Policy Change
    Gloria Lin (Taiwan Breast Cancer Alliance, Taiwan)
15:10-16:10
Free Paper V
Tumor and Cell Biology
Venue: MGB I
  • SIMULTANEOUS PERTURBATION OF TGFBETA AND EGF SIGNALING REVEALS SHARED NETWORK IN REGULATION OF THE CELL PROLIFERATION
    Min Jia (Department of Oncology-pathology, Karolinska Institutet, Sweden) 
  • PROMOTER METHYLATION OF RASSF1A MODULATES THE EFFECT OF MICROTUBULE-TARGETING AGENT, DOCETAXEL, IN BREAST CANCER
    Kyong Hwa Park (Department of Oncology/Internal Medicine, Korea Univ., Korea)
  • AURORA KINASE REGULATES TPA-INDUCED MMP-9 EXPRESSION IN MCF-7 BREAST CANCER CELLS
    Hyun Jo Youn (Department of Breast Thyroid Surgery, Chonbuk National Univ. Hospital, Korea)
  • UPREGULATION OF VEGF-A AND CD24 GENE EXPRESSION BY THE TGLI1 TRANSCRIPTION FACTOR CONTRIBUTES TO THE AGGRESSIVE BEHAVIOR OF BREAST CANCER CELLS
    Hui-Wen Lo (Department of General Surgery, Duke Univ., U.S.A.)
Free Paper VI
Detection and Diagnosis
Venue: Vista III
  • FACTORS ASSOCIATED WITH INVASIVE CARCINOMA IN THE PATIENTS DIAGNOSED WITH DUCTAL CARCINOMA IN SITU IN INITIAL BIOPSY
    Jina Chang (Department of General Surgery, School of Medicine, Ehwa Womans Univ., Korea)
  • INTRADUCTAL MASS ON BREAST ULTRASOUND (US): FINAL OUTCOMES AND PREDICTORS OF MALIGNANCY 
    Won Hwa Kim (Department of Radiology, Seoul National Univ. Hospital, Korea)
  • SECOND-LOOK ULTRASOUND EXAMINATION FOR MRI-DETECTED BREAST LESIONS IN BREAST CANCER PATIENTS
    Su Hyun Lee (Department of Radiology, Seoul National Univ. Hospital, Korea)
  • ONE-STEP NUCLEIC ACID AMPLIFICATION (OSNA) FOR THE DIAGNOSIS OF SENTINEL LYMPH NODES OF BREAST CANCER - CHINA MULTICENTER STUDY CBCSG-001C
    Yong-Sheng Wang (Breast Cancer Center, Shandong Cancer Hospital & Institute, China)
Free Paper VII
Detection and Diagnosis & Prognosis and Response Prediction & Quality of Life
Venue: Vista I+II
  • HER2 POSITIVE AND TRIPLE NEGATIVE SUBTYPES OF DUCTAL CARCINOMA IN SITU: IMAGING AND PATHOLOGIC FEATURES
    Min Sun Bae (Department of Radiology, Seoul National Univ. Hospital, Korea)
  • COMPARISONS THE NOMOGRAM TO OTHER PREDICTIVE TOOLS (ADJUVANT! ONLINE, ST. GALEN CONSENSUS, AND CS-IHC4) IN HORMONE RECEPTOR (HR)-POSITIVE BREAST CANCERS
    Yeon Hee Park (Department of Hematology-oncology, Samsung Medical Center, Korea)
  • P95HER2 AND PTEN AS SUPPLEMENTAL PREDICTIVE MARKERS TO ANTI-HER2 THERAPY: INTERIM ANALYSIS OF AN OBSERVATIONAL BIOMARKER STUDY
    Soonmyung Paik (NSABP & Samsung Cancer Research Institute, U.S.A./Korea)
  • PROPOSAL OF A BREAST CANCER-SPECIFIC PROGNOSTIC MODEL AND A NOMOGRAM TO PREDICT OUTCOMES FOR PATIENTS WITH BRAIN METASTASES (BM) FROM BREAST CANCER
    Hee Kyung Ahn (Division of Hematology-oncology, Samsung Medical Center, Korea)
  • CHARACTERIZATION OF FUNCTIONING OF BREAST CANCER SURVIVORS USING ONLINE HEALTH CONSULTATION WITH THE HELP OF ICF
    Eun Joo Yang (Department of Rehabilitation, Seoul National Univ. Bundang Hospital, Korea)
Free Paper VIII
Oncology Nursing
Venue: MGB II
  • HEALING CANCER: SELF-HELP IN CYTOKINE MANAGEMENT THROUGH EXERCISE, STRESS MANAGEMENT, AND DIET THROUGHOUT THE CANCER CONTINUUM
    Stellie Kim (Greater Bay Region, American Cancer Society, U.S.A.)
  • EFFECT OF AN INTEGRATE BREAST HEALTH MANAGEMENT PROGRAM FOR PREGNANT WOMEN ON KNOWLEDGE, ATTITUDE, EARLY SCREENING PRACTICE ABOUT BREAST CANCER
    Eun-Young Jun (Department of Nursing, Korea Nazarene Univ., Korea)
  • THE CHARACTERISTICS OF BREAST CANCER IN WOMEN OVER THE AGE OF 80
    Rumiko Tashima (Department of General Surgery, Kumamoto City Hospital, Japan)
  • QUALITY OF LIFE AND SYMPTOM EXPERIENCE IN BREAST CANCER SURVIVORS AFTER PARTICIPATING IN A PSYCHOEDUCATIONAL SUPPORT PROGRAM: A PILOT STUDY
    Jin-Hee Park (College of Nursing, Ajou Univ., Korea)
  • EFFECTIVENESS OF EXPRESSIVE WRITING PROGRAM FOR WOMEN WITH BREAST CANCER IN KOREA
    Eun Young Park (Department of Nursing Science, Gachon Univ. of Medicine and Science, Korea)
16:20-17:40
Panel VI
Bridging Bench to Clinic for Young Investigators: New Paradigm for Cancer Cure
Venue: Vista I+II
  • Understanding the Breast Cancer Stem Cells: Novel Paradigm for Cancer Treatment
    Dong-Young Noh (Department of General Surgery, Seoul National Univ. Hospital, Korea)
  • Understanding the Circulating Tumor Cells
    Seung Il Kim (Department of General Surgery, Yonsei Univ. Severance Hospital, Korea)
  • Therapies Targeting Cancer Stem Cell
    Jae Hong Seo (Department of Medical Oncology, Korea Univ. Guro Hospital, Korea)
Panel VII
Breast Cancer Cure and Beyond (QoL)
Venue: MGB I
  • A Double-edged Sword, Aromatase Inhibitor; Let's Take Action on Bone, Now!
    Yumie Rhee (Department of Internal Medicine, College of Medicine, Yonsei Univ., Severance Hospital, Korea)
  • Long-term Survivorship with the Patient's View, Supporting System
    Evaon C. Wong-Kim (Department of Social Work, California State Univ., Easy Bay, U.S.A.)
  • Individualized Postoperative Follow-up Based on the KI-67 Index for the Risk of Relapse and Recurrence Time for Breast Cancer Patients
    Reiki Nishimura (Department of Breast & Endocrine Surgery, Kumamoto City Hospital, Japan)
Back to Previous Meetings